We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

AI Model Could Help Diagnose Spinal Cord Disease Up To 30 Months Earlier

By HospiMedica International staff writers
Posted on 26 Feb 2026

Cervical spondylotic myelopathy (CSM) is the leading cause of spinal cord dysfunction in older adults and occurs when arthritis in the neck compresses the spinal cord. More...

The condition is chronic and progressive, often causing neck pain, muscle weakness, walking difficulties and other disabling symptoms. Diagnosis can take years because early signs are frequently overlooked, and by the time it is recognized, treatment options may be limited. Researchers have now developed an artificial intelligence (AI)-based method that can identify individuals at risk of CSM up to 30 months before clinical diagnosis, potentially enabling earlier intervention and improved outcomes.

A multidisciplinary team of surgeon-scientists and computer scientists at Washington University in St. Louis (WashU, St. Louis, MO, USA) created and evaluated seven different AI models to analyze electronic health record data from more than two million individuals with and without CSM. The models examined patterns of health care interactions, including diagnostic tests and recorded conditions, to identify patients whose medical histories resemble those already diagnosed with CSM. Both large foundation models pretrained on extensive clinical datasets and smaller, clinically informed models focusing on relevant variables, were trained and tested to predict risk well before formal diagnosis.

The models were trained using a large external dataset and a smaller dataset from a St. Louis–based health system to assess prediction accuracy across different time horizons. The foundation models performed best during internal validation on a large, heterogeneous dataset, while the smaller, clinically derived model demonstrated stronger generalizability and more consistent results across external systems. Two mid-scale models underperformed across the evaluated time points. The findings, published in npj Digital Medicine, show that risk for CSM can be predicted as early as 30 months before a clinical diagnosis, with simpler models incorporating clinical insight achieving comparable or superior performance.

Earlier identification of CSM risk could allow clinicians to intervene at a stage when treatment may prevent further neurological decline. By screening electronic health records for subtle warning patterns, the AI system may help flag patients who would otherwise remain undiagnosed until advanced stages. The researchers suggest that combining deep learning with established clinical knowledge may improve AI applications across health care. Future work will focus on refining the models and evaluating their integration into real-world clinical workflows.

“We were able to achieve at least comparable, if not superior performance with a much, much simpler model by focusing on existing clinical knowledge while still using a deep learning model,” said Assistant Professor Jacob Greenberg, MD, co-senior author of the study. “AI clearly has emerging opportunities in medicine, but we often focus only on the areas where purely data-driven solutions excel. There’s still an important role for clinical knowledge, which is going to be true for a lot of applications in health care.”

Related Links:
WashU


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.